Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Atlas Venture Associates IX, LLC

Q3 2022 · 13F-HR

Atlas Venture Associates IX, LLCholdings as filed

Filed 2022-11-10 · accession 0001104659-22-116783

$33,739
Reported value
6
Positions
2022-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83067L109SKILLZ INC$23,36869.3%22,909,859CommonSOLE
86877M209SURFACE ONCOLOGY INC$3,0639.08%2,945,453CommonSOLE
84833T103SPROSPERO THERAPEUTICS INC$2,7548.16%1,376,968CommonSOLE
87166L100SYNLOGIC INC$2,5197.47%2,651,963CommonSOLE
83304A106SNAPSNAP INC$1,4754.37%150,160CommonNONE
45826J105NTLAINTELLIA THERAPEUTICS INC$5601.66%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.